186 related articles for article (PubMed ID: 18362148)
21. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
[TBL] [Abstract][Full Text] [Related]
23. Lysosomal cysteine proteases and antigen presentation.
Rudensky A; Beers C
Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
[TBL] [Abstract][Full Text] [Related]
24. A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
Bevec T; Stoka V; Pungercic G; Cazzulo JJ; Turk V
FEBS Lett; 1997 Jan; 401(2-3):259-61. PubMed ID: 9013899
[TBL] [Abstract][Full Text] [Related]
25. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney.
Ogrinc T; Dolenc I; Ritonja A; Turk V
FEBS Lett; 1993 Dec; 336(3):555-9. PubMed ID: 8282126
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
27. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
28. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
[TBL] [Abstract][Full Text] [Related]
30. Shark class II invariant chain reveals ancient conserved relationships with cathepsins and MHC class II.
Criscitiello MF; Ohta Y; Graham MD; Eubanks JO; Chen PL; Flajnik MF
Dev Comp Immunol; 2012 Mar; 36(3):521-33. PubMed ID: 21996610
[TBL] [Abstract][Full Text] [Related]
31. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
32. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
Maubach G; Lim MC; Kumar S; Zhuo L
Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
[TBL] [Abstract][Full Text] [Related]
33. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
35. Anti-cathepsin L monoclonal antibodies that distinguish cathepsin L from cathepsin V.
Kopitar-Jerala N; Bevec T; Barlic-Maganja D; Gubensek F; Turk V
Biol Chem; 2001 May; 382(5):867-70. PubMed ID: 11517943
[TBL] [Abstract][Full Text] [Related]
36. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
[TBL] [Abstract][Full Text] [Related]
37. Identification of putative cathepsin S in mangrove red snapper Lutjanus argentimaculatus and its role in antigen presentation.
Zhou J; Li L; Cai ZH
Dev Comp Immunol; 2012 May; 37(1):28-38. PubMed ID: 22210546
[TBL] [Abstract][Full Text] [Related]
38. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family.
Katunuma N; Kakegawa H; Matsunaga Y; Saibara T
FEBS Lett; 1994 Aug; 349(2):265-9. PubMed ID: 8050579
[TBL] [Abstract][Full Text] [Related]
39. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization.
Brömme D; Li Z; Barnes M; Mehler E
Biochemistry; 1999 Feb; 38(8):2377-85. PubMed ID: 10029531
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
